Category: Business

Clemson Eye Integrates Two Greenville Eye Care Practices into Its Network

GREENVILLE, S.C.–(BUSINESS WIRE)–This spring, Clemson Eye, Upstate’s leading provider of advanced eye care with highly trained surgeons and the latest technology, will unite with two prominent Greenville eye health practices — Montgomery & Riddle Eyecare and Donelson Eye Associates — under the Clemson Eye brand name. Combined, these practices form one of the most respected and advanced eye care systems in the nation, serving more than 100,000 patients and offering more than 10 specialties

Global Eyewear Market Trends, Share, Size, Growth, Opportunity and Forecast (2019-2024): Projected to Cross $141 Billion by 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Eyewear Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering. The global eyewear market was worth US$ 120 Billion in 2018, registering a CAGR of 3.4% during 2011-2018. The market is further projected to cross US$ 141 Billion by 2024, at a CAGR of 2.6% during 2019-2024. Currently, the global demand for good-quality eyewear products is being augmented by increasing prevalen

Asia Pacific Cataract Surgery Devices Market Forecast to 2024 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Cataract Surgery Devices Market (2018 – 2024)” report has been added to ResearchAndMarkets.com’s offering. The Asia Pacific Cataract Surgery Devices Market is expected to witness market growth of 6.1% CAGR during the forecast period 2018-2024. Cataract surgery devices are majorly used in surgical procedures that are focused on treating cataract, an eye disorder which clouds the lens, and as a result, leads to defects in vision. Cataract is among the mo

Rhino-Conjunctivitis – Pipeline Insight, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Rhino-Conjunctivitis – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Rhino-Conjunctivitis development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, as

Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active Thyroid Eye Disease (TED) Met Primary and All Secondary Endpoints

DUBLIN–(BUSINESS WIRE)–Horizon Pharma plc (Nasdaq: HZNP) today announced topline results from its Phase 3 confirmatory trial evaluating teprotumumab for the treatment of active thyroid eye disease (TED). The study met its primary endpoint, showing mo…